NDSIB
BMY icon

North Dakota State Investment Board’s Bristol-Myers Squibb BMY Stock Holding History

North Dakota State Investment Board’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.73M Sell
61,512
-10,967
-15% -$639K 0.16% 89
2025
Q4 		$3.91M Buy
+72,479
New +$3.49M 0.15% 105

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

North Dakota State Investment Board's BMY Position: Q1 2026 in Review

North Dakota State Investment Board reduced its Bristol-Myers Squibb (BMY) stake by 15% in Q1 2026, selling an estimated $639K and leaving 61,512 shares worth $3.73M. The position accounts for 0.16% of the portfolio, ranked #89.

North Dakota State Investment Board first reported a position in BMY in Q4 2025 and has held it in 2 quarters since. The position peaked at $3.91M in Q4 2025. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • North Dakota State Investment Board held 61,512 shares of Bristol-Myers Squibb worth $3.73M as of Q1 2026.
  • North Dakota State Investment Board sold 10,967 Bristol-Myers Squibb shares in Q1 2026, an estimated $639K.
  • Bristol-Myers Squibb made up 0.16% of North Dakota State Investment Board's portfolio in Q1 2026, its #89 holding.
  • North Dakota State Investment Board first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 2 quarters since.
  • North Dakota State Investment Board's Bristol-Myers Squibb position peaked at $3.91M in Q4 2025.
  • 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on North Dakota State Investment Board's 13F filing for Q1 2026, filed 8 May 2026.